Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 65.75
-0.35 (-0.53%)
At close: Feb 6, 2026
SHA:603087 Revenue
Gan & Lee Pharmaceuticals. had revenue of 980.24M CNY in the quarter ending September 30, 2025, with 5.39% growth. This brings the company's revenue in the last twelve months to 3.85B, up 30.54% year-over-year. In the year 2024, Gan & Lee Pharmaceuticals. had annual revenue of 3.05B with 16.77% growth.
Revenue (ttm)
3.85B
Revenue Growth
+30.54%
P/S Ratio
10.17
Revenue / Employee
733.53K
Employees
5,245
Market Cap
39.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 437.31M | 16.77% |
| Dec 31, 2023 | 2.61B | 895.77M | 52.31% |
| Dec 31, 2022 | 1.71B | -1.90B | -52.60% |
| Dec 31, 2021 | 3.61B | 250.16M | 7.44% |
| Dec 31, 2020 | 3.36B | 466.82M | 16.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Winner Medical | 10.80B |
| Intco Medical Technology | 9.85B |
| Zhende Medical | 4.32B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.12B |
| Imeik Technology Development | 2.52B |
| Shenyang Xingqi Pharmaceutical | 2.41B |
| iRay Group | 2.30B |
| Autek China | 1.82B |